Thrivent Financial For Lutherans Ionis Pharmaceuticals Inc Transaction History

Thrivent Financial For Lutherans

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $1.91 Million - $2.38 Million	54,910 Added 5.89%	987,450 $40.5 Million
Q1 2023 May 17, 2023	BUY	$33.58 - $41.2 $443,524 - $544,169	13,208 Added 1.44%	932,540 $33.3 Million
Q4 2022 Feb 08, 2023	BUY	$37.12 - $46.52 $402,863 - $504,881	10,853 Added 1.19%	919,332 $34.7 Million
Q3 2022 Nov 14, 2022	SELL	$36.54 - $48.66 $13.5 Million - $17.9 Million	-368,304 Reduced 28.85%	908,479 $40.2 Million
Q2 2022 Aug 16, 2022	SELL	$31.71 - $43.0 $9.03 Million - $12.2 Million	-284,730 Reduced 18.23%	1,276,783 $47.3 Million
Q1 2022 May 13, 2022	BUY	$29.88 - $37.04 $822,118 - $1.02 Million	27,514 Added 1.79%	1,561,513 $57.8 Million
Q4 2021 Feb 16, 2022	BUY	$25.61 - $35.1 $3.75 Million - $5.13 Million	146,235 Added 10.54%	1,533,999 $46.7 Million
Q3 2021 Nov 15, 2021	BUY	$33.54 - $40.55 $42.4 Million - $51.3 Million	1,264,397 Added 1024.91%	1,387,764 $46.5 Million
Q2 2021 Aug 19, 2021	BUY	$34.54 - $47.25 $70,945 - $97,051	2,054 Added 1.69%	123,367 $4.92 Million
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $5.16 Million - $7.74 Million	121,313 New	121,313 $5.45 Million
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $25,150 - $32,195	-500 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$45.56 - $59.57 $22,780 - $29,785	500	500 $25,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

Stay updated on Thrivent Financial For Lutherans with notifications on news.